ClearPoint Neuro, Inc. (CLPT) earnings: date, estimates, results and stock reactions
Over the last 12 reports the stock moved 12.5% on average (either way), rising 6 times and falling 6. EPS beat estimates 4 of 12 times; revenue 6 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).
| Quarter | Reported | EPS | EPS estimate | EPS surprise | Revenue | Revenue estimate | Stock move |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-10-28 | -0.24 | -0.32 | +23.8% | 12.1M | 12.3M | +10.3% |
| Q2 FY2026 | 2026-08-03 | -0.38 | -0.29 | -32.6% | 10.9M | 12.7M | -13.8% |
| Q1 FY2026 | 2026-05-13 | -0.32 | -0.28 | -14.3% | 12.1M | 12.0M | +1.0% |
| Q4 FY2025 | 2026-03-17 | -0.27 | -0.22 | -22.7% | 10.4M | 10.1M | -12.9% |
| Q3 FY2025 | 2025-11-06 | -0.21 | -0.20 | -5.0% | 8.9M | 10.4M | -6.9% |
| Q2 FY2025 | 2025-08-12 | -0.21 | -0.20 | -5.0% | 9.2M | 9.8M | +12.5% |
| Q1 FY2025 | 2025-05-13 | -0.22 | -0.15 | -46.7% | 8.5M | 9.2M | -8.9% |
| Q4 FY2024 | 2025-02-26 | -0.20 | -0.15 | -33.3% | 7.8M | 8.2M | -15.0% |